Moreover, siRNA-mediated STAT3 inhibition reduced the total protein levels of tumor-promoting genes Mcl1, Cyclin D1, VEGF, and Bcl-XL, suggesting that STAT3 is required for proliferation and survival in Olaparib-resistant cells (Figure 2F). The gene discussed is MCL1; the disease is neoplasm.